Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02137863

Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy

Radiographic Contrast Agent Nephropathy Clinical Trial

Official title:
Phase 4 Study of Dexmedetomidine Effects on Preventing Contrast Induced Nephropathy

Clinical Trial Summary

The aim of this study was to evaluate the effects of dexmedetomidine on renal function, hormonal and hemodynamic parameters in contrast media induced diabetic patients.

Clinical Trial Description

Contrast nephropathy may occur after using intravenous contrast media and may result in acute renal failure. Contrast nephropathy usually reversible but in some cases it can be permanent. This situation increase the time of hospitalization and mortality of the patients. Although the only proved prevention from contrast nephropathy method is hydration, infusion of dexmedetomidine may keep the renal functions. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02137863
Study type Interventional
Source TC Erciyes University
Contact
Status Completed
Phase Phase 4
Start date June 2011
Completion date July 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT00540904 - Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate Phase 2
Recruiting NCT00584350 - Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Phase 4
Recruiting NCT01820195 - N-Acetyl Cystein and Contrast Nephropathy Phase 3
Completed NCT01866800 - The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI Phase 4
Active, not recruiting NCT01778140 - Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System N/A
Completed NCT02483143 - NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial Phase 4
Completed NCT01525888 - Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy N/A
Recruiting NCT02643706 - Relationship Between ALDH2 and CIN N/A
Terminated NCT01168024 - Contrast Media Reduction and Removal in Patients With CKD (PRESERV) Phase 3
Completed NCT02643602 - Does Bicarbonate in Addition to Theophylline Reduce CIN? N/A
Recruiting NCT02029820 - RenalGuard System for Prevention of Contrast Induced Nephropathy Phase 3
Terminated NCT01654328 - Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy N/A